Baker, Michael J., and Kirk L. Hamilton Ϫ secretion of the mouse jejunum. Genistein stimulated a sustained increase in Isc that was dose dependent. Bumetanide inhibited 76 Ϯ 5% of the genistein-stimulated Isc consistent with activation of Cl Ϫ secretion. Genistein failed to stimulate Isc following maximal activation of the cAMP pathway by forskolin. In addition, forskolin had a reduced effect on Isc of the mouse jejunum in the presence of genistein. Glibenclamide, a blocker of CFTR, eliminated the genistein-stimulated increase of Isc and reduced the forskolin-activated Isc. Clotrimazole, a Ca 2ϩ -activated K ϩ channel blocker, failed to reduce the genistein-stimulated Isc. Vanadate, a blocker of tyrosine-dependent phosphatases, reduced the genisteinactivated Isc. Tyrphostin A23, a tyrosine kinase inhibitor, reduced basal Isc, after which genistein failed to stimulate Isc. These data suggest that genistein activated a sustained Cl Ϫ secretory response of the mouse jejunum and that the effect of genistein was via a tyrosinedependent phosphorylation pathway.
1-ethyl-2-benzimidazolone; vanadate; tyrphostin A23; cantharidic acid; phosphatase GENISTEIN is an isoflavone phytoestrogen that occurs naturally in a number of members of Leguminosae (18) . It is found in many soy products, including soybeans, tofu, soy flour, and soy milk (7) . Genistein is structurally related to estradiol, an endogenous estrogen, and has been demonstrated to bind to estrogen receptors (36) . Genistein and other phytoestrogens have been linked with a range of potential health benefits, including prevention of breast and prostate cancer and cardiovascular disease and reduction of clinical symptoms of obesity and diabetes, among others (7, 38) . Genistein is known to inhibit tyrosine kinase (1, 2) , DNA topoisomerase II (42) , and protein histidine kinase (30) .
Genistein has been reported to alter a number of ion transport proteins, such as the cystic fibrosis transmembrane conductance regulator (CFTR; the cAMP-dependent Cl Ϫ channel) (13, 17, 24, 33, 34, 39, 41, 56) , K ϩ channels (17, 34) , and Na ϩ -K ϩ -2Cl Ϫ cotransporter (43) , in native epithelia and cultured epithelial cell lines. Recently, genistein was proposed as a possible pharmacotherapy for cystic fibrosis by modulation of Cl Ϫ secretion (37, 48) . Channel activity of CFTR is reciprocally regulated by kinase-dependent phosphorylation and phosphatase-dependent dephosphorylation of nuclear-binding domains 1 and 2 (NBD1 and NBD2), respectively (22, 53) . Therefore, CFTR is modulated by protein kinases (35) , protein phosphatases (6, 35, 40, 54) , and inhibitors of protein kinases and phosphatases (5, 34) .
The mechanisms of action of genistein on CFTR include inhibition of tyrosine kinase (35, 52) , modulation of CFTR by inhibition of protein phosphatases (34, 35, 46, 60) , and direct activation of CFTR (3, 21, 45, 55, 57) . Illek et al. (35) first demonstrated that genistein activated the CFTR via a tyrosinedependent pathway by inhibiting a tyrosine kinase. In addition, Illek et al. (35) demonstrated that vanadate, an inhibitor of protein tyrosine phosphatase (25) , prevented the genisteininduced activation of CFTR expressed in NIH/3T3 cells. Likewise, genistein activated Cl Ϫ secretion in the rat colon; however, the action of genistein was suppressed by pretreatment of vanadate (17) . Interestingly, Wang et al. (55) demonstrated that genistein activated CFTR in the presence of vanadate with excised patch-clamp experiments of CFTR expressed in Hi-5 insect cells. Tyrphostin 47, a tyrosine kinase inhibitor structurally unrelated to genistein, increased short-circuit current (I sc ) of endogenous CFTR of human colonic epithelial monolayers (T84) (52); however, tyrphostin A23 and tyrphostin A51 did not stimulate transepithelial Cl Ϫ secretion in T84 monolayers (34) . Tyrphostin 47 failed to stimulate Cl Ϫ current via CFTR, whereas genistein did stimulate Cl Ϫ current for CFTR heterologously expressed in Xenopus oocytes (57) . Thus the role of genistein in the tyrosine-dependent regulation of Cl Ϫ secretion via CFTR is not well defined.
Non-tyrosine kinase effects of genistein on CFTR and the Cl Ϫ secretory response have been reported. Genistein has been suggested to regulate CFTR by inhibiting protein phosphatases (35, 46, 60) . Indeed, direct effects of genistein on CFTR have been suggested. French et al. (21) and Weinreich et al. (57) , using patch-clamp studies of heterologously expressed CFTR, reported that genistein increased the activity of CFTR and speculated that genistein interacts directly with CFTR at NBD2. Randak et al. (45) , using a fusion protein of NBD2, provided the first biochemical evidence that genistein interacts with the NBD2 of CFTR, thus inhibiting the NBD2 activity, and suggested that a similar mechanism could explain the genistein-dependent stimulation of Cl Ϫ current via CFTR. Indeed, Al-Nakkash et al. (3) demonstrated that genistein stabilizes the open state of CFTR by inhibiting ATP hydrolysis at NBD2.
However, additional effects of genistein in cellular function include reduction of pp60 c-src activity and reduction of nitrite levels and inducible nitric oxide synthase (iNOS) activity. Wijetunge et al. (59) reported that genistein reduced the channel current of L-type Ca 2ϩ channels of smooth muscle cells of isolated rabbit ear arteries by reducing the pp60 c-src activity. Chang et al. (11) suggested that induction of iNOS and nitrite accumulation in rat kidney mesangial cells occurs via a genistein-sensitive pathway. Similarly, Scuro et al. (51) showed that genistein reduced iNOS expression and nitric oxide production in mouse macrophages. Therefore, genistein has many effects on a wide number of cellular functions.
In the mammalian intestine, the small intestine (jejunum) is the primary site for secretion and absorption of fluid and electrolytes (10) . Electrogenic Cl Ϫ secretion is the primary transport mechanism responsible for fluid secretion within the crypt region (58) . In this process, the combined action of the basolateral membrane Na ϩ -K ϩ -2Cl Ϫ cotransporter, Na ϩ /K ϩ -ATPase, and K ϩ channel results in the level of Cl Ϫ being raised above its electrochemical equilibrium within the cell. Then, upon the action of a secretagogue, Cl Ϫ exits across the apical membrane via Cl Ϫ channels (CFTR) (47) . Coordinated activity of these transporters must occur for a sustained Cl Ϫ secretory response to occur. Other than a recent report on the effects of genistein in the murine colon (24) , very little is known about the action of genistein on the Cl Ϫ secretory response of the mouse small intestine, and of the jejunum, in particular.
There were two aims of this study: first, to examine the action of genistein on the Cl Ϫ secretory response of the mouse jejunum, and second, to begin to unravel the action of genistein on the Cl Ϫ secretory response.
MATERIALS AND METHODS

Animals and tissue preparation.
All experiments were performed on the jejunum of male Swiss-Webster mice (20 -35 g ) and were approved by the University of Otago Animal Ethics Committee. The animals had access to tap water and a low-soy diet ad libitum until an experiment began. Mice were killed by cervical dislocation, and the intact isolated jejunum was placed in a NaCl Ringer's solution (in mM: 140 NaCl, 5 KCl, 2 CaCl 2, 1 MgCl2, 10 HEPES/Tris, and 4 pyruvate/glutamine, with pH adjusted to 7.4). HEPES-buffered Ringer's was used to examine only HCO 3 Ϫ -independent Cl Ϫ secretion. Electrophysiological measurements: Ussing chamber experiments. The Ussing chamber I sc experiments were performed as previously described (27, 28) . Tissues were glued (Loctite 454; Loctite, Welwyn City, UK) to plastic annuli (0.7 cm 2 ) and mounted in modified Ussing chambers. The epithelium was bathed on both mucosal and serosal sides with 10 ml of the NaCl Ringer's solution. Solutions were aerated (100% O 2) and maintained at 37°C with the use of water-jacketed solution reservoirs.
Tissues were voltage clamped to 0 mV (Biodesign; South Campus Electronics, University of Otago) and I sc was continuously recorded with a MacLab data acquisition system (AD Instruments, Castle Hill, Australia) (8, 28) . Data analysis was performed with MacLab Chart (version 3.6.3; AD Instruments). All tissues were pretreated with indomethacin (1 M, mucosal and serosal sides) to reduce prostaglandin production (19) and with tetrodotoxin (0.6 M, serosal side) to reduce enteric nerve activity (31) for 1 h (total time) to reduce transepithelial transport to basal conditions. The basal I sc was 116 Ϯ 3 A/cm 2 (n ϭ 66). The change in Isc (⌬Isc) induced by a treatment was expressed as the difference between the former baseline value and the steady-state value. Dose-response curves were fit with the Hill equation. The presence of the circular and longitudinal muscle layers surrounding the jejunum did not impede access of chemicals to the epithelium as exhibited by very rapid responses of I sc with the addition of forskolin or bumetanide (see Figs. 1, 3, 4, 6, and 8) .
Chemicals. Genistein, HEPES, bumetanide, cantharidic acid, forskolin, sodium orthovanadate, indomethacin, glibenclamide, and clotrimazole were purchased from Sigma Chemical (St. Louis, MO). 1-Ethyl-2-benzimidazolone (1-EBIO) was purchased from Tocris Cookson. Tris was obtained from BDH Chemicals (Poole, UK). Tyrphostin A23 (A18) was purchased from LC Laboratories (Woburn, MA). Genistein, 1-EBIO, forskolin, glibenclamide, clotrimazole, tyrphostin A23, and forskolin were dissolved in dimethyl sulfoxide (DMSO), bumetanide was dissolved in ethanol, and indomethacin was dissolved in methanol. The vehicles did not alter I sc. Tetrodotoxin was purchased from Alomone Labs (Jerusalem, Israel) and dissolved in distilled water. Drugs were added as a small volume of a stock solution as indicated in the text unless otherwise noted.
Statistical analysis. Statistical significance was assessed using Student's t-test (paired and unpaired). MacCurveFit (Kevin Raner Software, Victoria, Australia) was used for curve fitting and to determine the K m, Hill coefficients, and Vmax values of the doseresponse experiments. Data are presented as means Ϯ SE. In some figures, the SE bar is within the data point. A P value of 0.05 was considered significant. The number (n) of tissues used in each series of experiments is provided in the text.
RESULTS
Effect of genistein on the I sc of mouse jejunum: Cl
Ϫ secretion. Initially, we examined whether genistein could activate a I sc response in the mouse jejunum. Genistein (50 M, mucosal and serosal) stimulated a sustained increase in I sc (Fig. 1A , n ϭ 36) that was significantly greater than the change in I sc of control tissues (Fig. 1B , n ϭ 10). The change in I sc produced by genistein was not correlated with the basal I sc (data not shown, n ϭ 66). The increase in I sc activated by genistein was dose dependent (1-100 M) ( 
Genistein has been demonstrated to activate Cl
Ϫ secretion in a number of native tissues and cultured cells (17, 24, 34, 35, 39, 41) . Therefore, we used bumetanide, an inhibitor of the Na ϩ -K ϩ -2Cl Ϫ cotransporter, to assess whether the genisteinstimulated I sc was due to Cl Ϫ secretion. Indeed, bumetanide (10 M, serosal) significantly reduced the genistein-stimulated I sc by 76 Ϯ 5% consistent with activation of Cl
Others have demonstrated that phosphorylation of CFTR is required for participation in the stimulatory response of genistein (17, 21, 35, 46, 60) . Clearly in the mouse jejunum, genistein alone activates Cl Ϫ secretion (Fig. 1) ; however, we wanted to assess whether prior phosphorylation of CFTR would augment the dose response of genistein on the I sc of the mouse jejunum. Therefore, tissues were bathed in a NaCl Ringer's solution and pretreated with a low concentration of forskolin (0.25 M, mucosal and serosal) before the addition of genistein. The pretreatment of forskolin increased I sc by 22 Ϯ 8 A/cm 2 . The dose-response curve of genistein in the presence of forskolin is shown in Fig. 2 , B and C (circles, n ϭ 4). The K m of the dose response of genistein in the presence of forskolin was shifted to 23 Ϯ 6 M but was not significantly different from that in the absence of forskolin (34 Ϯ 3 M). Similarly, V max (34 Ϯ 6 and 34 Ϯ 2 A/cm 2 ) and the Hill coefficients (2.7 Ϯ 1.8 and 3.5 Ϯ 0.6) were not altered in the presence and absence of forskolin, respectively.
These (21, 32, 35, 55, 57) . We predicted that if CFTR participates in the genistein response of the mouse jejunum, then genistein would not alter I sc in the presence of a maximum concentration of forskolin, an activator of CFTR via cAMP. To test this hypothesis, tissues were bathed in NaCl Ringer's solution and either pretreated with a maximum concentration of forskolin (10 M, mucosal and serosal; unpublished data) followed by the addition of genistein (50 M, mucosal and serosal) or treated with DMSO before the addition of genistein. Pretreatment of tissues with forskolin increased I sc by 106 Ϯ 8 A/cm 2 ( Fig. 3B , n ϭ 10). As noted above, genistein stimulated a sustained increase in I sc in the absence of forskolin, as shown in Fig. 3A (n ϭ 5) . However, in the presence of a maximally forskolin-stimulated I sc response, genistein failed to further increase I sc (Fig. 3B, n ϭ 10) . These experiments are summarized in Fig. 3C .
Working from these data, we predicted that if CFTR participates in the genistein-activated I sc response, then pretreating tissues with genistein would reduce the forskolin-stimulated I sc response of the mouse jejunum. To test this hypothesis, tissues were bathed in NaCl Ringer's solution and subjected to genistein (50 M, mucosal and serosal) followed by forskolin (10 M, mucosal and serosal) or to DMSO followed by forskolin (Fig. 4, A and B) . Indeed, forskolin alone increased I sc by 129 Ϯ 28 A/cm 2 (n ϭ 3), a response that was significantly reduced by 35% when forskolin was added in the presence of genistein (84 Ϯ 4 A/cm 2 ; Fig. 4C , n ϭ 7). Furthermore, glibenclamide, a known blocker of CFTR (50, 53) , was used to confirm the role of CFTR in the genisteinstimulated I sc response. Recently, we reported that mucosal rather than serosal application of glibenclamide reduced methoxsalen-stimulated Cl Ϫ secretion of the mouse jejunum (27) , suggesting that glibenclamide did not have access to the opposite side of the epithelium. In this series of experiments, all tissues were bathed with NaCl Ringer's solution. Experimental tissues were pretreated (30 min) with glibenclamide (100 M, mucosal) whereas control tissues received DMSO, after which genistein (50 M, mucosal and serosal) was added to all tissues. Genistein activated I sc as previously demonstrated (n ϭ 8); however, genistein failed to stimulate I sc in the presence of glibenclamide (Fig. 5A, n ϭ 7) . Because glibenclamide prevented genistein's activation of I sc , we wanted to confirm that glibenclamide could reduce forskolin-stimulated I sc , as well. In fact, in experiments similar to those described above, pretreatment of tissues with mucosal glibenclamide (100 M) reduced the forskolin (10 M, mucosal and serosal)-stimulated I sc by 60% (Fig. 5B, n ϭ 3 ).
These results demonstrate that genistein and forskolin increase the I sc of the mouse jejunum via a similar pathway and suggest that CFTR participates in the genistein-activated increase in I sc .
Effect of genistein on a maximally 1-EBIO-activated I sc . 1-EBIO is a known activator of K ϩ channels, particularly the intermediate-conductance Ca 2ϩ -dependent K ϩ channel (IK Ca ) (15, 28) . Also, 1-EBIO has been reported to stimulate intracellular levels of cAMP in native tissue (12) and to increase the activity of CFTR in cultured cells (14) . Investigators (Carter DJ, Hamilton KL, and Butt AG, unpublished observations) have demonstrated that 1 mM 1-EBIO stimulates a maximal I sc response of the mouse jejunum bathed in HEPES-buffered Ringer's solution. The IK Ca is present in the basolateral membrane of isolated mouse jejunal crypts and is activated by 1-EBIO (9, 28). Therefore, it was of interest to examine the effects of genistein in the presence of a maximum concentration of 1-EBIO. To examine these effects, tissues were bathed in NaCl Ringer's solution and either pretreated with 1-EBIO (1 mM, serosal, 20 min) followed by the addition of genistein (50 M, mucosal and serosal) or treated with genistein alone. Genistein stimulated a sustained increase in I sc in the absence of 1-EBIO, as shown in Fig. 6A (n ϭ 7) . Interestingly, in the presence of a maximally 1-EBIO-stimulated response, genistein further increased I sc (Fig. 6B, n ϭ 15) . However, the genistein-stimulated increase in I sc in the presence of 1-EBIO was significantly less than in the absence of 1-EBIO (Fig. 6C) . These data suggest that genistein may be increasing the activity of CFTR and/or altering the basolateral K ϩ conductance. IK Ca is not involved in genistein-stimulated I sc . The above data suggest that genistein increases I sc of the mouse jejunum with the cooperation of CFTR. However, to establish a sustained I sc secretory response, there must be an increase in the basolateral K ϩ conductance coupled with the increase in apical Cl Ϫ conductance (i.e., CFTR activity) or, alternatively, a basal K ϩ conductance must be large enough to maintain a driving force for Cl Ϫ to exit across the apical membrane (13, 47) . IK Ca is one of the predominant K ϩ channels of the basolateral membrane of the mouse jejunum (9, 28) . In fact, we recently reported that methoxsalen, a psoralen, stimulated a sustained increase Cl Ϫ secretory response of the mouse jejunum with the participation of CFTR and activation of the basolateral IK Ca (27) . To determine whether IK Ca is involved in the genisteinstimulated I sc response, we examined the effects of clotrimazole, a known blocker of IK Ca (16) , on the action of genistein on the I sc of the mouse jejunum. In this series of experiments, all tissues were bathed with NaCl Ringer's solution. Experimental tissues were pretreated (30 min) with clotrimazole (10 M, serosal), whereas control tissues received DMSO, after which genistein (50 M, mucosal and serosal) was added to all tissues. Clotrimazole had no effect on the action of genistein in that genistein had a similar effect on I sc whether clotrimazole was present or not (19 Ϯ 3 and 17 Ϯ 6 A/cm 2 in the absence and presence of clotrimazole, respectively; n ϭ 5-6) (data not shown). These data suggest that the basolateral IK Ca does not participate in the genistein-stimulated response.
Influence of genistein on phosphorylation of CFTR? The overall channel activity of CFTR, and thus the rate of Cl Ϫ secretion, is reciprocally regulated by kinase-dependent phosphorylation and phosphatase-dependent dephosphorylation of nuclear-binding domains (22, 53) . Therefore, we examined the effects of cantharidic acid, an inhibitor of the serine/threonine protein phosphatase type 2A (PP2A) (29) , sodium orthovanadate (vanadate), an inhibitor of protein tyrosine phosphatases (25) , and tyrphostin A23 (23), a tyrosine kinase inhibitor, on the stimulatory action of genistein. To test the involvement of serine protein phosphatases in the genistein-stimulated I sc response, tissues were pretreated (30 min) with either cantharidic acid (5 M, serosal) or with DMSO followed by the addition of genistein (50 M, mucosal and serosal). Genistein alone activated a sustained increase in I sc (Fig. 7A) . Cantharidic acid had no effect on the basal current (Fig. 7B) ; however, the genistein-stimulated I sc was greater in the presence than in the absence of cantharidic acid (Fig. 7, B and C, n ϭ 11). The time dependence of the activation of I sc by genistein was not different in the absence (670 Ϯ 115 s) or presence (641 Ϯ 90 s) of cantharidic acid (n ϭ 11). These results suggest that genistein does not increase I sc by inhibition of PP2A.
Vanadate was used to examine whether inhibition of tyrosine protein phosphatases participated in the genistein-activated I sc (25) According to a protocol similar to that described above, tissues were pretreated with vanadate (100 M, mucosal and serosal) or with Ringer's solution followed by the addition of genistein (50 M, mucosal and serosal). As shown in Fig. 8 , A and C, genistein increased I sc . Vanadate reduced the basal I sc ; however, the genistein response was reduced in the presence of vanadate compared with control tissues (Fig. 8 , B and C, n ϭ 3). In addition, the effect of forskolin (10 M, mucosal and serosal) on the I sc was reduced in the presence of vanadate (Fig. 8, B and C) . The effect of bumetanide on the genistein-and forskolin-stimulated I sc in the presence of vanadate suggests that the Na ϩ -K ϩ -2Cl Ϫ cotransporter and, thus, the Na ϩ -K ϩ -ATPase were operating (Fig. 8B) . As reported by Illek et al. (35) , the reduced response of genistein in the presence of vanadate suggests the interplay of both protein tyrosine phosphatases as well as protein tyrosine kinases. Tyrphostin A23, an inhibitor of protein tyrosine kinase, was used to test whether genistein was activating I sc by inhibiting a protein tyrosine kinase that had a negative influence on CFTR (35) . Initially, tissues were bathed in NaCl Ringer's solution pretreated with either tyrphostin A23 (100 M, mucosal and serosal) or DMSO, after which genistein (50 M, mucosal and serosal) was added to the tissues. Tyrphostin A23 reduced the basal I sc by 30 Ϯ 3 A/cm 2 (n ϭ 5; data not shown). Genistein failed to increase I sc in the presence of tyrphostin A23 (Ϫ2 Ϯ 1 A/cm 2 , n ϭ 3) but stimulated a robust I sc in control tissues (27 Ϯ 5 A/cm 2 , n ϭ 3; data not shown). To test the viability of the tissues, ouabain (2 mM, serosal) reduced the I sc of all tissues. Lower concentrations of tyrphostin A23 (20 and 50 M) produced inconsistent results (data not shown).
These data suggest that the action of genistein on Cl Ϫ secretion of the mouse jejunum is likely via a tyrosine phosphorylation-dependent pathway.
DISCUSSION
The jejunum is a dominant site of fluid secretion by the small intestine (10). In the current article, we report the first description of the effect of genistein on the secretory response of the intact mouse jejunum. Genistein alone stimulated a sustained I sc response of the jejunum (Fig. 1) . Because the mouse jejunum is capable of electrogenic Cl Ϫ secretion (26, 28), we used bumetanide to confirm that the genistein-stimulated I sc was indeed Cl Ϫ secretion. Bumetanide inhibited 76% of the genistein-activated I sc consistent with stimulation of Cl Ϫ secretion (Fig. 1B) . The residual genistein-stimulated I sc may result from HCO 3 Ϫ secretion (26), but HCO 3 Ϫ would have to be generated from cellular sources, because these experiments were conducted in HEPES-buffered Ringer's solution.
Others have reported that genistein can activate CFTR in heterologously expressed CFTR in expression systems, cultured cell lines, and a few native tissues (13, 17, 21, 24, 32-35, 39, 46, 52, 55, 60) . The mechanism of action of genistein on the Cl Ϫ secretory response is still a matter of contention. In some studies, genistein alone elicits a sustained secretory response; however, investigators in other studies report that CFTR must be phosphorylated before the addition of genistein to initiate a stimulatory effect (35, 46, 60) . Clearly, genistein can activate CFTR directly, as has been demonstrated with cell-attached and excised patches of various cell types (21, 32, 35, 55, 57) . It has been demonstrated that a basal level of activity of protein kinase A, and thus phosphorylation of CFTR via cAMP, is clearly necessary for stimulation of CFTR by genistein in other studies (46, 60) . However, elevated levels of cAMP are not mandatory for a stimulatory action of genistein, because many have reported genistein-stimulated Cl Ϫ secretion without changes of intracellular cAMP (33-35, 39, 52 ).
In the current study, genistein alone stimulated a robust sustained Cl Ϫ secretory response in the mouse jejunum (Fig. 1 ) as has been reported by others for a native tissue (24) and cultured cells (13, 24, 52 ). However, we report that prior phosphorylation of CFTR did not alter the efficacy of genistein, as shown in the dose-response experiments (Fig. 2) . In the presence of phosphorylated CFTR, concentrations Ͼ100 M genistein caused a reduction in I sc . This may be due to inhibition of K ϩ channels by genistein (17, 34, 41) ; however, recent evidence from our laboratory showed that 125 and 200 M genistein increased I sc of the mouse jejunum by 37 Ϯ 6 and 35 Ϯ 5 A/cm 2 , respectively (Chao PCT and Hamilton KL, unpublished data). This finding is in agreement with the dose-response curve in the current study (Fig. 2, squares) . Nonetheless, Deiner and Hug (17) clearly demonstrated that the genistein-stimulated I sc response of the rat colon was quite small but was greatly enhanced in the presence of a low concentration of forskolin (0.2 M). Similarly, heterologously expressed CFTR in a variety of expression systems (NIH/3T3 fibroblasts and Hi-5 insect cells) required a basal level of protein kinase A activity to ensure a stimulatory effect of genistein (34, 46, 60) .
Sustained genistein response on I sc . The nature of the sustained Cl Ϫ secretory response stimulated by genistein in the present study suggests that various components of the Cl Ϫ secretory pathway (e.g., CFTR, K ϩ channels) may be upregulated (47). It is not surprising to conclude that the genistein response involves the participation of CFTR (55, 57) .
Several lines of evidence suggest that CFTR is the Cl Ϫ channel participating in the genistein response of the mouse jejunum. First, CFTR is expressed in the mammalian intestine and has been identified in the mouse jejunum in particular (4). Second, pretreatment of the jejunum with a maximum concentration of forskolin to maximally activate (phosphorylate) CFTR prevented a further increase in I sc by genistein (Fig. 3) . Third, pretreatment of the jejunum with genistein reduced the forskolin-stimulated I sc (Fig. 4) , suggesting that genistein and forskolin may use a common pathway for increasing Cl Ϫ secretion by the mouse jejunum. Finally, glibenclamide, a known inhibitor of CFTR (50, 53) , prevented an increase in I sc by genistein and reduced the I sc activated by forskolin (Fig. 5A ).
Genistein's effect on basolateral K ϩ conductance. Genistein has varying effects on K ϩ channels of epithelial and nonepithelial tissues. Genistein has inhibitory effects on basolateral Ca 2ϩ -activated K ϩ channels as previously reported for the human rectum, rat colon, and CFTR-expressing colonic cell lines (17, 34, 41) . Alternatively, genistein has been reported to stimulate a small-conductance, Ca 2ϩ -activated K ϩ channel of rat cortical collecting ducts (56) and K ϩ channels of human lung adenocarcinoma and fibroblast cultured cells (49) . Therefore, it is possible that genistein may increase Cl Ϫ secretion of the mouse jejunum by activating basolateral K ϩ channels. An increased K ϩ conductance (activation of K ϩ channels) would hyperpolarize the jejunal cells, resulting in an enhanced driving force for Cl Ϫ secretion. The IK Ca is one of the more prevalent K ϩ channels of the basolateral membrane of the mouse jejunum (9, 28) . Thus we examined the effect of clotrimazole, a specific blocker of IK Ca (16) , on the ability of genistein to stimulate a Cl Ϫ secretory response. However, in the presence of clotrimazole, genistein still activated a sustained Cl Ϫ secretory response, suggesting that IK Ca does not participate in the genistein response. This finding does not preclude the possibility that another type of K ϩ channel may be activated by genistein. However, it is possible that the basal K ϩ conductance of the jejunal epithelium may be adequate to maintain the driving force for Cl Ϫ secretion as has been suggested for other secretagogues (13) .
Additional evidence suggesting that genistein may not be activating IK Ca comes from the 1-EBIO/genistein experiments (Fig. 6 ). In the presence of a maximal 1-EBIO stimulation of I sc [presumably a maximal activation of IK Ca (28) ], genistein clearly stimulated I sc , lending further support to the possibility that genistein is not activating IK Ca and, thus, may be stimulating Cl Ϫ secretion via CFTR as has been reported by others (21, 35, 55) .
It is possible that genistein is activating another type of K ϩ channel. If this were so, then we would have expected genistein to increase I sc in the presence of a maximum concentration of forskolin, which did not occur. It is conceivable that forskolin leads to the activation of multiple types of K ϩ channels; therefore, genistein might not have the opportunity to exhibit any further effect on I sc . Indeed, the reduced effect of forskolin on I sc in the presence of genistein (Fig. 4) suggests that if genistein is activating a basolateral K ϩ channel, then that channel may also be involved in the forskolin-stimulated I sc response of the mouse jejunum. In support of this hypothesis, we have demonstrated that both the IK Ca and cAMP-dependent K ϩ channels participate in the forskolin-stimulated I sc of the mouse jejunum (Carter DJ, Hamilton KL, and Butt AG, unpublished data).
Tyrosine phosphorylation, CFTR, and genistein. Gating of CFTR can be regulated by phosphorylation and ATP hydrolysis and is modulated by the action of protein phosphatases at the nuclear-binding domains of CFTR (6, 60) . Studies have reported that genistein modulates Cl Ϫ secretion by altering the overall phosphorylated state of CFTR by inhibition of either protein kinases (35, 52) or protein phosphatases (34, 35, 46, 60) . Therefore, if the observed genistein-stimulated secretory response (i.e., I sc ) of the mouse jejunum occurs via inhibition of a serine phosphatase, for instance, then prior treatment with a serine phosphatase inhibitor should reduce the efficacy of genistein. Alternatively, if tyrosine kinase phosphorylation is involved in the genistein-activated Cl Ϫ secretory response, then we would expect an associated tyrosine phosphatase to be involved (57) , and thus the inhibition of that phosphatase should alter the action of genistein.
PP2A has been demonstrated to dephosphorylate CFTR (6, 60) and reduce the activity of CFTR (40) . Cantharidic acid, a known inhibitor of PP2A (29) , failed to prevent the action of genistein in the present study. Indeed, tissues pretreated with cantharidic acid exhibited an increased I sc , stimulated by genistein. The enhanced genistein response in the presence of cantharidic acid may result by cantharidic acid preinhibiting specific phosphatases, thus permitting an action of genistein to proceed without a time lag imposed by dephosphorylation events, or else another phosphatase(s) may be inhibited by genistein. Nonetheless, genistein's action on the Cl Ϫ secretory response of the mouse jejunum was clearly independent of PP2A. These results are consistent with others showing that genistein exhibited a further effect on 125 I efflux of CFTRexpressing NIH/3T3 fibroblasts in the presence of calyculin A, an inhibitor of PP2A (46) . Similarly, Wang et al. (55) demonstrated that genistein increased CFTR channel current in the presence of saturating concentrations of forskolin and calyculin A in cell-attached patches of CFTR-expressing NIH/3T3 fibroblasts and Hi5 insect cells.
Regulation of tyrosine phosphorylation has been proposed to modulate CFTR, and thus Cl Ϫ secretion, in native tissue (39) and cultured cells (35, 52) . In the present study, vanadate, an inhibitor of tyrosine protein phosphatase (25) , greatly reduced the genistein-stimulated I sc (Fig. 8) . One explanation for the reduced genistein response in the presence of vanadate is that the protein tyrosine kinase-induced phosphorylation exerts a negative effect on CFTR channel activity and, hence, reduced Cl Ϫ secretion (35) . Therefore, pretreating tissues with vanadate thus yields increased tyrosine phosphorylation, resulting in blocking of the stimulatory effect of genistein (35) . Illek et al. (35) demonstrated that vanadate reversibly inhibited genisteinstimulated CFTR currents in cell-attached patches of CFTRtransfected NIH/3T3 fibroblasts as well as genistein-stimulated 125 I efflux via CFTR. In the current study, it is possible that vanadate inhibited the Na ϩ -K ϩ -ATPase; however, we observed bumetanide-sensitive I sc in the presence of vanadate (Fig. 8B) , suggesting that the Na ϩ -K ϩ -2Cl Ϫ -cotransporter as well as the Na ϩ -K ϩ -ATPase was still functional. Nonetheless, our data provide additional support for the contention of Illek et al. (35) that genistein regulates CFTR, and thus Cl Ϫ secretion, via a tyrosine kinase-dependent pathway.
A perplexing result was that tyrphostin A23 reduced basal I sc and prevented any stimulatory effect by genistein in the mouse jejunum. Tyrphostins are a class of tyrosine kinase inhibitors that are structurally different from genistein. Genistein contains an isoflavone structure (2) . It has been suggested that the action of particular tyrosine kinase inhibitors on transport function is dependent on the structural nature of the inhibitor (43) . Indeed, Niisato et al. (43) demonstrated that tyrphostin A23 (100 M) reduced I sc and Cl Ϫ conductance in renal epithelial A6 cells, whereas genistein increased I sc . Similarly, Illek et al. (34) reported that tyrphostin A23 (50 M) and tyrphostin 51 (40 M) failed to stimulate Cl Ϫ secretion in the human colonic T84 cell line even though genistein clearly activated Cl Ϫ secretion. In contrast, Yang et al. (60) demonstrated that tyrphostin 51 enhanced forskolin-activated CFTR channel activity in CFTR-expressing Hi-5 insects cells. In the present study, the lack of response of genistein in the presence of tyrphostin A23 may be the result of inhibition of the Na
Ϫ cotransporter by tyrphostin A23 as recently reported (44) . However, others are not convinced that there are kinase inhibitors that totally inhibit the Na ϩ -K ϩ -2Cl Ϫ cotransporter (20 
